Photopheresis in GvHD After Hematopoietic Transplantation: Characteristics of the Procedure and of the Cell Product

Conditions: Graft Vs Host Disease, Extracorporeal Photopheresis

Sex: All

Ages: 18 Years – N/A

Enrollment: 30

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Location: Italy

Summary

This is an observational study on extracorporeal photopheresis,an established therapy for the treatment of Graft versus Host Disease (GvHD) post allogeneic haemopoietic stem cell transplantation. There are different techniques and devices to perform cell collection procedure, photoactivation and infusion of mononuclear cells.We will enrol patients undergoing allogeneic transplants and extracorporeal photopheresis in order to understand whether the different ways in which photopheresis is performed affect cell products and clinical response.

Eligibility Criteria

Inclusion Criteria:diagnosis of GvHD post allogeneic HSC transplantation being treated with photopheresis;signing of informed consent (IC) and consent to personal data processingExclusion Criteria:-

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05718674). StuddyBuddy aggregates publicly available trial information.